Category Archives: Myocardial Infarction

This article was originally published here Am J Med. Continue reading →

This article was originally published here Curr Cardiol Rep. 2021 May 7;23(6):69. doi: 10.1007/s11886-021-01501-7. Continue reading →

Patients suffering a heart attack received percutaneous coronary intervention (PCI), a procedure to clear blocked arteries in the heart, an average of 10 minutes faster after clinicians and paramedics began using an app to facilitate efficient hospital intakes for these patients, according to a study being presented at the American College of Cardiologys 70th Annual Scientific Session. The study was conducted at Baystate Medical Center, a health system headquartered in Springfield, Massachusetts, that, like many U.S. Continue reading →

The report on Myocardial Infarction Drug market intent to make the readers aware about the latest development in this business sphere, including Covid-19 aftermath, to aid in informed decision making. The highly detailed Myocardial Infarction Drug market research report predicts the future behaviour of this business sphere through expert opinions on the past and current industry development data. It highlights the key growth markers, opportunities, as well as the restraints existing in the marketplace Continue reading →

REDWOOD CITY, Calif. & NEPTUNE BEACH, Fla.--(BUSINESS WIRE)--HeartFlow, Inc., a leader in revolutionizing precision heartcare, and MedAxiom, an American College of Cardiology (ACC) company whose mission is to transform cardiovascular care and improve heart health, announced today a collaboration to improve cardiovascular care for patients with coronary artery disease (CAD). The collaboration will focus on increasing awareness among providers and payors about the coronary computed tomography angiography (CTA) and HeartFlow FFRct Analysis diagnostic pathway, and equipping practitioners with the tools they need to best adapt their practices to utilize CTA more broadly Continue reading →

A new study found that a restrictive blood transfusion strategy had comparable outcomes to a liberal transfusion strategy in patients with acute myocardial infarction and anemia. Continue reading →

Healed myocardial infarction is common among people who suffer sudden death, far outnumbering acute MI, Norwegian autopsy data show. Continue reading →

Coronary artery disease, or heart disease, is caused by atherosclerosis, a process which involves the accumulation of cholesterol plaques in the arteries that supply blood to the heart. These plaques can narrow the blood vessels and reduce blood and oxygen delivery to the heart (called ischemia), leading to symptoms like chest pain. Continue reading →

The global stem therapy market growth will be driven by extensive R&D activities aimed at developing novel therapies and personalized medicines. For example, to treat patients who have suffered a myocardial infarction (heart attack), scientists are emphasizing on developing techniques to regenerate healthy heart from placental stem cells. As per the Centers for Disease Control and Prevention (CDC), heart diseases in the U.S. Continue reading →

Nicholas C. Johnson, PharmD Candidate, Class of 2021 and Adebola Akunna, PharmD, BCPS As research has ensued, more harmful compounds have been found present in e-cigarette aerosol, similar to the well-established negative health outcomes associated with traditional tobacco cigarettes.2,3 Although it has been established that e-cigarette vapors, by and large, contain fewer total compounds than traditional tobacco cigarettes, they often still contain numerous toxic substances, albeit at lower concentrations.4 Atherosclerosis and Nicotine Nicotine, the primary shared compound between e-cigarette and traditional tobacco, has been a well-established catalyst for the development of atherosclerotic cardiovascular disease. Nicotine has been shown to induce the release of catecholamines and cortisol, cause hemodynamic changes (increased blood pressure, heart rate, and vasoconstriction), and cause adverse changes in lipid profiles (increased saturated fat content, decreased unsaturated fat content, and increased total cholesterol).5 Additionally, e-cigarette users have been found to have significantly decreased vascular elasticity, which may lead to heart disease and stroke, along with similar inflammatory infiltrate of the vasculature seen in cigarette smokers that lead to atherosclerosis over time.5 Other findings that correlate to nicotine exposure, either first- or second-hand, include aortic stiffness, insulin resistance, inhibition of apoptosis, and promotion of angiogenesisall of which may accelerate atherosclerotic (and malignancy) progression Continue reading →